GE Healthcare has opened its first integrated development center (IDC) at Manipal Hospital in Bangalore, India, to support clinical trials for GE products.
The IDC facility is expected to conduct around 1,000 scans annually as part of clinical trials in support of new GE contrast and molecular imaging agents, or for new indications of existing agents. The center will be part of a series of global clinical studies in the U.S., the European Union, and several other countries, according to the Chalfont St. Giles, U.K.-based vendor.
Under the terms of the collaboration, physicians at Manipal Hospital will act as study investigators and provide clinical and imaging services and administration in the hospital. The first studies at the facility will focus on Visipaque (iodixanol), an isosmolar contrast agent that was launched globally by GE Healthcare in 1996.
By AuntMinnie.com staff writers
June 29, 2006
Related Reading
GE debuts revenue management system, June 26, 2006
GE signs deal with UltraSPECT, June 22, 2006
GE to acquire Biacore, June 20, 2006
GE adds to remote IT services, June 19, 2006
GE gets vet CT install, June 14, 2006
Copyright © 2006 AuntMinnie.com
